| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +381 | 100% | $13.13 | +$5,003 |
| Sells | 0 | ||||
| Net | +1 | +381 | 100% | +$5,003 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Daniel R. Chard | Chairman & CEO, Director | $4,336,047 | +$5,003 | +0.12% | 13 Jun 2025 |
| Kevin G. Byrnes | Director | $1,027,977 | 11 Nov 2021 | ||
| James P. Maloney | Chief Financial Officer | $606,991 | 25 Mar 2025 | ||
| Jeffrey J. Brown | Director | $573,487 | 25 Jun 2025 | ||
| Ming Xian | Director | $430,393 | 25 Jun 2025 | ||
| Michael A. Hoer | Director | $351,575 | 25 Jun 2025 | ||
| Scott Schlackman | Director | $343,630 | 25 Jun 2025 | ||
| Andrea B. Thomas | Director | $323,030 | 25 Jun 2025 | ||
| Elizabeth A. Geary | Director | $262,880 | 25 Jun 2025 | ||
| Jonathan Barrett MacKenzie | VP, Finance & CAO | $159,830 | 25 Mar 2025 | ||
| Constance J. Hallquist | Former Director | $148,251 | 06 Oct 2023 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Ming Xian | MED | Restricted Stock Units (cash settled) | Award | 114.8% | 17,181 | 32,143 | 25 Jun 2025 | Direct | ||
| Scott Schlackman | MED | Common Stock | Award | 77.7% | 11,168 | 25,549 | 25 Jun 2025 | Direct | ||
| Andrea B. Thomas | MED | Common Stock | Award | 86.9% | 11,168 | 24,017 | 25 Jun 2025 | Direct | ||
| Michael A. Hoer | MED | Common Stock | Award | 74.6% | 11,168 | 26,139 | 25 Jun 2025 | Direct | ||
| Elizabeth A. Geary | MED | Common Stock | Award | 133.3% | 11,168 | 19,545 | 25 Jun 2025 | Direct | ||
| Jeffrey J. Brown | MED | Common Stock | Award | 114.8% | 20,617 | 38,578 | 25 Jun 2025 | Direct | ||
| Daniel R. Chard | MED | Common Stock | Purchase | 0.26% | $5,003 | $13.13 | 381 | 149,698 | 13 Jun 2025 | The Dan and Allyson Family Irrevocable Trust |
| James P. Maloney | MED | Common Stock | Award | 133.2% | 24,161 | 42,299 | 25 Mar 2025 | Direct | ||
| Jonathan Barrett MacKenzie | MED | Common Stock | Award | 221.3% | 7,671 | 11,138 | 25 Mar 2025 | Direct | ||
| Daniel R. Chard | MED | Common Stock | Award | 243.6% | 124,953 | 176,246 | 25 Mar 2025 | Direct | ||
| Jonathan Barrett MacKenzie | MED | Common Stock | Tax liability | -2.78% | -99 | 3,467 | 17 Mar 2025 | Direct | ||
| James P. Maloney | MED | Common Stock | Tax liability | -2.36% | -438 | 18,138 | 17 Mar 2025 | Direct | ||
| Daniel R. Chard | MED | Common Stock | Tax liability | -3.51% | -1,864 | 51,293 | 17 Mar 2025 | Direct | ||
| Jonathan Barrett MacKenzie | MED | Common Stock | Tax liability | -1.65% | -60 | 3,566 | 16 Mar 2025 | Direct | ||
| James P. Maloney | MED | Common Stock | Tax liability | -0.66% | -123 | 18,576 | 16 Mar 2025 | Direct | ||
| Daniel R. Chard | MED | Common Stock | Tax liability | -1.74% | -944 | 53,157 | 16 Mar 2025 | Direct |